PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

CPhI – Festival of Pharma: Dose eye drops even more precisely with DropControl

Düsseldorf, October 14, 2020. With DropControl, Gerresheimer has developed a new type of dropper insert for modern drugs with low viscosity for ophthalmology, whi...
Continue Reading →
News

Abzena invests $60m into cGMP manufacturing capacity

The facility will enable the company to deliver Phase I to commercial manufacturing services for biologic projects. Abzena, a contract provider of integrated disco...
Continue Reading →
News

Biologics manufacturing and diagnostics need resiliency, says Scott Gottlieb

Former FDA Commissioner lays out roadmap for building out excess capacity to deal with pandemic situations The ongoing COVID-19 pandemic means resiliency is likely...
Continue Reading →
News

Cambrex completes major expansion of solid form screening facility in Edinburgh

The expansion increases the company's capacity and provides its clients with larger process crystallization development, up to 20-L scale. Cambrex has completed an...
Continue Reading →
News

Recipharm to boost sterile liquids manufacturing capacity

The investment will support increased demand and help to secure new business at its Kaysersberg facility. Global contract development and manufacturing organisatio...
Continue Reading →
News

J&J’s COVID-19 vaccine trial paused on safety concerns

Johnson & Johnson has put its COVID-19 vaccine trial on hold after a participant in the phase III study developed an unexplained illness. Following the patient...
Continue Reading →
News

Redhill expands manufacturing for COVID-19 candidate

Redhill Biopharma has announced partnerships with two specialist pharmaceutical manufacturers in Europe and Canada to increase manufacturing for its COVID-19 candida...
Continue Reading →
News

Iksuda Therapeutics exercises licensing rights from University of Goettingen

UK-based biotech company Iksuda Therapeutics has executed its option to secure exclusive worldwide rights to develop a new class of tumour-activated prodrug payloads...
Continue Reading →
News

Bone Therapeutics showcases allogeneic cell therapy data

Bone Therapeutics has announced positive 24-month follow-up results from its phase IIa study of Allob, its allogeneic cell therapy, in patients undergoing lumbar spi...
Continue Reading →
News

The Virtual Conference Format Is Improving – But Is It A Worthy Replacement?

In January, Dora Wirth (Languages) Limited (DWL), attended our last face-to-face conference, in the Netherlands, before the COVID-19 outbreak signalled an end to con...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026